August 12, 2018
Article
An Extraordinary Healer essay honoring JADE HERING, B.S.N., RN, OCN [BETH ISRAEL DEACONESS MEDICAL CENTER, AMBULATORY HEMATOLOGY ONCOLOGY BMT, BOSTON, MASSACHUSETTS]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC